Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change
Journal of General Internal Medicine
January 2021
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Full Citation
Huang A, Wu X, Orloff J, Min JY, Flory J. Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change. J Gen Intern Med. 2021 Jan 6. doi: 10.1007/s11606-020-06380-2. Epub ahead of print. PMID: 33409883.
Tags
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- Journal of General Internal Medicine
Literature Type
- PCORI Research